SUBSCRIBE
SUBSCRIBE
News   Deals

QLT Inc. Gets Rights to Sell Visudyne in US from Novartis Pharma AG (JOBS)

October 19, 2009 | 
1 min read

Bookmark and Share

Reuters -- Canadian eye-care company QLT Inc said it restructured its pact with Novartis Pharma AG, giving it exclusive rights to sell anti-blindness treatment Visudyne in the United States.

Mergers & acquisitions
MORE ON THIS TOPIC
Podcast
BridgeBio’s ATTR-CM Approval, Cassava’s Alzheimer’s Failure, Trump’s Cabinet Picks, More
November 27, 2024
 · 
1 min read
 · 
Heather McKenzie
Art collage, coins, and arrow up on the red and paper background. Concept of business and financial growth.
Deals
Sarepta Aims Up to $10B at Arrowhead to Diversify Pipeline With RNA Drugs
November 26, 2024
 · 
2 min read
 · 
Kate Goodwin
Roche's signage at its office in France
Mergers & acquisitions
Roche Buys Poseida for up to $1.5B, Leaning Into Off-the-Shelf CAR T
November 26, 2024
 · 
3 min read
 · 
Tristan Manalac
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Mergers & Acquisitions
Novartis CEO Promises More Deals of Up to $5B, With an Eye for Early Science
November 21, 2024
 · 
2 min read
 · 
Annalee Armstrong